Syreon Corporation

Who We Are


Syreon is a dynamic contract research organization specializing in the use of electronic systems for international health research and clinical trials. Syreon combines advanced computing technologies, specialized therapeutic expertise and global reach to provide leading edge clinical research programs and CRO services ideally adapted to the fast pace of modern drug evaluation.

Syreonís clinical research programs offer a full suite of support services including study design, project management, site selection, site monitoring, data management, biostatistics, and health economics and outcomes research.

ClinStream™


Our powerful Syreon ClinStream™ electronic clinical research system links research partners in over 40 countries with speed, security and accuracy, and enables the seamless integration of clinical, laboratory, health outcomes and health economics data for comprehensive clinical evaluation of treatment effectiveness and value.

Clients


Syreon CRO partners with an elite portfolio of global pharmaceutical corporations, emerging biotechnology companies and academic networks to identify therapeutic trends, streamline new drug investigation, monitor clinical use and economic value, and control development costs by accelerating time to market in today's competitive clinical research environment.

  • News and Updates ||

  • * March 10, 2014: Syreon is pleased to announce the opening of their office in Tirgu Mures, Romania. Syreon Research Romania can be contacted at www.syreon.ro
    * August 28, 2013: Syreon Corporation Initiates Observational Study in Cystic Fibrosis. Press Release
    * August, 2013: Syreon has successfully completed a multicentre, multi-country international phase IV study to track disease prevalence, presentation and management of sexually communicated viral disease in the Middle East and Eastern Europe.
    * August, 2013: Syreon will initiate enrolment in Canada into a non-interventional study comparing treatment convenience and compliance for treatment of participants with Cystic Fibrosis.
    * June, 2013: Syreon has successfully completed enrolment of 3300 participants into a Phase IV study in Canada and Europe to track medication use patterns, treatment satisfaction and inadequate control of osteoporosis in postmenopausal women. The participants will continue to be followed over the next year.
    * September, 2012: Syreon commences enrolment into a new acute multicentre surgical study. The study will examine innovative intervention in post-surgical care across the United States.
    * July, 2012: Syreon expands parallel group study of reproductive health across Europe, Asia and Australia. The study will investigate new therapy across more than 175 sites in 15 countries on three continents.
    * June, 2012: Syreon initiates a study of retinal disease in 20 leading ophthalmology research sites across Canada. The study will investigate health treatment, resource use and productivity assessments.
    * June, 2012: Syreon expands a longitudinal study of glaucoma to include Europe. The study will now explore the clinical outcome, health status and economics of glaucoma across almost 50 sites in Europe & North America.
    * May, 2012: Syreon launches an observational study in acute surgical management across 10 sites in the U.S. The study will be conducted using ClinStream™ electronic study software with real-time data analysis and study reporting.
    * November, 2011: Syreon expands study of communicable disease to involve Russia. The study will assess disease prevalence, and†burden of illness across all regions of the country.
    * November, 2011: Syreon launches a multi-national study of diabetes in South America. This multicentre study including 2,000 subjects is designed to explore the therapeutic management of diabetes and hyperlipidemia across several South American countries and to map clinical practice and health outcomes in subjects with newly diagnosed diabetes mellitus.
    * September, 2011: Syreon launches a multicentre US controlled study linking 35 sites and enrolling 450 subjects to explore the treatment, of glaucoma. This study will follow patients for three years to explore the clinical outcome, health status and economics of glaucoma care in the United States.
    * June, 2011: Syreon initiates a multicentre international phase IV study including over 3,000 subjects in Europe to track the use of prophylactic and therapeutic medications in osteoporosis, and the outcomes, consequences and health and economic impact and of treatment. The study will be conducted using ClinStream™ electronic study software with real-time data analysis and study reporting.
    * June, 2011: Syreon initiates a global phase IV study investigating reproductive technologies and health outcomes. The study will be conducted using ClinStream™ electronic study software with real-time data analysis and study reporting.
    * March, 2011: Syreon has launched an update of its highly recognized and fully validated ClinStream™ e-clinical research management application developed specifically for multi-national "direct-to-patient" clinical studies. This new flexible format, adapted for both MS and Mac operating systems with multi-language capability, is designed to enable direct patient response within formal clinical studies. ClinStream™ is now capable of linking a virtually unlimited number of patients and study sites simultaneously to accelerate global interventional, observational and economics research with rigor and precision, offering reduced cycle time and enhanced value.
    * February, 2011: Syreon launches a multicentre international phase IV study including over 1,000 subjects in North America and Europe to track the symptoms and severity of migraine, the use of prophylactic and therapeutic medications, and the outcomes and consequences of treatment. The study will be conducted using ClinStream™ electronic study software with real-time data analysis and study reporting.
    * February, 2011: Syreon launches a multicentre, multi-country international phase IV study to track the population epidemiology, presentation and management of sexually communicated viral disease in the Middle East and Eastern Europe. The study will be conducted using ClinStream™ electronic study software with real-time data analysis and study reporting.
    * January, 2011: Syreon is in the process of a 5-year clinical support program for the clinical management and research analysis of biologics therapy in chronic disease involving over 30,000 subjects. This study, one of the largest of its kind in the world, is conducted electronically using a select version of the recognized ClinStream™ e-clinical research management application with specialized data entry for clinical care, automated data loading for simplified reporting, and on-line analytical processing to enable the accelerated cycle time required for clinical interpretation and management.
    * January, 2011: Syreon launches a multicentre international phase IV study including over 1,000 subjects in five countries in Europe to track the symptoms and severity of osteoarthritis, the use of prophylactic and therapeutic medications, and the outcomes and consequences of treatment. The study will be conducted using ClinStream™ electronic study software with real-time data analysis and study reporting.
    * January, 2011: Syreon launches a multicentre, national phase II study in North America in the field of cosmetic care to investigate the clinical use of biological therapy. The study will be conducted using ClinStream™ electronic study software with real-time data analysis and study reporting.